2026 Musculoskeletal Tumor Society (MSTS) Annual Meeting2026 European Society for Medical Oncology (ESMO) Congress (MSTS 2026 ChonDRAgon Secondary Efficacy Endpoints Oral[...]

Inhibrx Biosciences Inc. published this content on October 29, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 29, 2026 at 19:36 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]